Atlas Trials

Assessing Incretin Therapy for Cardiovascular Risk Reduction and Diabetes Remission( ITCRDR Study)

Clinical trial NCT06959784 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT06959784
Sponsor
China-Japan Friendship Hospital
Status
ENROLLING_BY_INVITATION
Phase
Phase 4
Study type
INTERVENTIONAL
Diabetes MellitusCardiovascular DiseasesCerebrovascular Disease
Start date
2024-01-01
Primary completion
2026-12-31
Enrollment
142

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.